Alps Group Inc

US$1.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALPSHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (50.30%)
Div yield —
ROE (200.87%)
Biotechnology
Beta (5Y) (0.09)
PE TTM —
TSR TTM (87.12%)
Mkt cap US$54.86M
ROIC (73.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.79
8.73%
(78.03%)
Hold 3|5|1|10|2
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.02
0.02
0.02
0.02
4.11%
(7.67%)
2.30%
(0.35%)
Revenue$M
6.689
6.930
7.091
7.175
(0.23%)
3.46%
7.00%
7.15%
Peers (US$54.86M)
Cap (US$)
PE
64.09M
4.166x
52.43M
11.61x
Capital
TTM
5Y
10Y
Leveragex
0.459
1.223
1.174
EBIT/Intx
0.490
0.107
0.101
Own earn%
79.48
(94.90)
(84.49)
Sh yield%
36.81
19.77
19.01
Owners
Insiders/Inst%
3.22
81.74
Short interest%
4.84
SBC / revenue%
2.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–17
$1 testx
−0.1
Incr. ROIC%
1